PRINCETON, N.J., March 29 /PRNewswire-FirstCall/ -- Pharmasset, Inc. announces that management will present at the Canaccord Adams Hepatitis C Conference being held Thursday April 1, 2010 at the Peninsula Hotel, New York, NY. Schaefer Price, Pharmasset’s President and Chief Executive Officer, will provide a review of the Company’s HCV drug pipeline at the conference at 2:00 PM (ET) and Mr. Patrick Higgins, Executive Vice President of Sales and Marketing will be participating in an HCV panel discussion at 3:00 PM (ET).
A replay of the webcast will be available on Pharmasset’s website for thirty days following the conference. The investor presentation will be available for download in PDF format immediately following the presentation in the “Events & Presentations” section of the Investor Center on Pharmasset’s website at http://investor.pharmasset.com/events.cfm.
Pegasys(R) and Copegus(R) are registered trademarks of Roche.
Pharmasset, Inc.
